Drug discovery company Compugen Ltd. (Nasdaq: CGEN; TASE: CGEN) announced today that Dr. Anat Cohen-Dayag, Ph.D., and Martin Gerstel have been named co-CEOs of the company.
Dr. Cohen-Dayag joined Compugen in 2002, and has held the positions of director of diagnostics, vice president for diagnostic biomarkers & drug targets, and most recently, vice president of R&D. Prior to joining Compugen, she was head of R&D and a member of the executive management at Mindsense Biosystems Ltd.
Dr. Cohen-Dayag holds a B.S. in Biology from Ben-Gurion University, and an M.S. in chemical immunology and a Ph.D. in cellular biology from the Weizmann Institute of Science.
Martin Gerstel joined Compugen in 1997 as chairman of the board, and served in that role until January of this year when he was appointed president and CEO. Prior to joining Compugen he was co-chairman and CEO of ALZA Corporation, which he helped found, and a director of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Gerstel currently serves as a director of various public and private companies including Evogene Ltd. and Itamar Medical Ltd. (TASE:ITMR), and various educational and civic organizations including the Weizmann Institute of Science, the Hebrew University, the US Foundation for the National Medals of Science and Technology, and the Israel-United States Binational Industrial Research and Development Foundation (BIRD-F).
Tel Aviv-based Compugen is a drug and diagnostic product candidate discovery company. It uses in-silico (by computer) prediction and selection, and resulting product candidates are then validated through in vitro and in vivo experimental studies and out-licensed for further development. Current collaborations include Biosite, Medarex, Inc., Merck & Co., Inc., Roche, Siemens Healthcare Diagnostics, Inc., and Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA).
Shares in Compugen closed at $1.25 yesterday, giving a market cap of $35.6 million.
Published by Globes [online], Israel business news - www.globes-online.com - on June 2, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009